Probiotics Fail to Reduce Stress in Major Gut-Brain Clinical Trial

Introduction

A probiotic strain widely hoped to blunt psychological stress failed to outperform placebo in one of the largest gut-brain trials to date. Researchers at the University of Auckland randomised 766 moderately stressed adults to eight weeks of Lactococcus lactis (strain FNZ339), Lactobacillus plantarum, or placebo. The result, published in Nutritional Neuroscience, is a sobering data point in the ongoing effort to use bacteria to treat mood.

What the Auckland Trial Actually Found

Led by Dr. R. F. Slykerman of the Department of Psychological Medicine, University of Auckland, the study used a five-arm design: participants took capsules containing either L. lactis FNZ339 or L. plantarum at one of two doses (1 × 10⁹ or 1 × 10¹⁰ colony-forming units daily), or placebo, for eight weeks. The primary outcome was stress on the Depression Anxiety Stress Scale (DASS-21).

Stress scores fell across the board. The L. lactis group dropped 5.2 points (SD 8.6); the placebo group dropped 5.6 points (SD 7.5). There was no meaningful difference. Anxiety, depression, sleep quality, salivary cortisol, and inflammatory markers all followed the same pattern — improvement everywhere, advantage nowhere.

A second complication emerged mid-trial. Viability testing revealed that counts of L. plantarum in the capsules had declined unexpectedly, leaving a dose far below anything considered therapeutic. The researchers excluded that arm from analysis entirely rather than report a misleading result — an honest call that itself shows how fragile probiotic manufacturing can be.

Why the Placebo Effect Dominates Mood Studies

A 5.6-point drop on the DASS-21 stress subscale in people taking nothing but capsules is not trivial. When participants expect to feel calmer, they often do. This is especially true in self-reported mood outcomes, where belief, attention, and repeated questioning all nudge scores downward. Small early probiotic studies — many with 20 to 50 participants and no placebo control — are highly vulnerable to exactly this effect. At 766 participants, the Auckland trial had the statistical power to separate a genuine effect from noise, and it found nothing.

The mechanism question remains open, though. The gut-brain axis is real: gut bacteria produce neurotransmitter precursors and metabolites such as short-chain fatty acids, and butyrate signals to the brain via FFAR2 receptors. Vagal nerve signalling and immune pathways carry further messages. What the Auckland data suggest is that this particular L. lactis strain, at the doses tested, does not move the needle in healthy-but-stressed adults — not that the axis itself is fiction.

Strain Specificity: Why This Negative Result Doesn’t Settle the Debate

Probiotics are not interchangeable. Lactobacillus plantarum, Bifidobacterium longum, and Lactococcus lactis differ genetically and functionally as much as a labrador differs from a wolf. Most positive psychobiotic evidence comes from specific strains — for example, B. longum 1714 and L. helveticus R0052 — tested in specific populations. A negative result for FNZ339 in moderately stressed healthy adults says little about other strains, higher-stakes clinical populations, or longer treatment periods.

Population matters too. Participants here were healthy adults with moderate stress, not people with diagnosed depression or anxiety disorders. Someone with clinical depression may have more room — and possibly more microbial disruption — for a probiotic to act on. Broader approaches to altering the microbiome, including psychobiotics and fecal microbiota transplantation for depression, remain an active research area with a different evidence base.

Practical Applications: What to Do While the Science Catches Up

If you’re managing stress or low mood alongside gut symptoms, the evidence points toward whole-diet and lifestyle levers first. Fermented foods such as kimchi and kefir increase microbiome diversity broadly rather than delivering a single strain. Fibre-rich plants feed the bacteria that produce butyrate, a compound with documented gut-brain signalling effects. For those with IBS, where mood and gut symptoms feed each other, exercise has been shown to ease both depression and digestive symptoms simultaneously.

For a specific probiotic supplement, be a sceptical consumer: look for the strain designation (not just the species), the dose in CFUs, and ideally a human trial behind it. And if you take one and feel better — well, the placebo data above shows that may still be worth something.

Frequently Asked Questions

Do probiotics work for stress and depression?

It depends entirely on the strain. This large trial found no benefit for Lactococcus lactis FNZ339 in moderately stressed adults, but other specific strains have shown modest effects in different populations.

Why did the placebo group improve so much?

Expectation effects are powerful in self-reported mood studies. When people enrol in a stress trial and take daily capsules, they tend to report feeling better regardless of what the capsule contains.

What is the gut-brain axis?

It’s the two-way communication network linking gut microbes to the brain through the vagus nerve, immune signalling, and microbial metabolites like butyrate — a mechanism that exists even though this particular probiotic didn’t activate it measurably.

Are fermented foods better than probiotic capsules for mood?

Possibly. Fermented foods influence the whole microbial community rather than one strain, and the diet-level evidence for mood support is at least as strong as the current single-strain supplement data.

Conclusion

The Auckland trial is a valuable correction to probiotic enthusiasm: 766 people, proper controls, honest reporting of a manufacturing failure, and a null result. It doesn’t dismantle the gut-brain axis — it refines it, showing that effects are strain-specific, dose-dependent, and easily drowned out by expectation. Until larger trials identify which strains reliably help whom, diet, fibre, and exercise remain the best-evidenced tools.

Sources:
https://pubmed.ncbi.nlm.nih.gov/42766151/